Predictors of Residual Viraemia in Patients on Long-Term Suppressive Antiretroviral Therapy
Lu Zheng(Harvard University), Robert Levaro, Lisa M. Demeter(University of Rochester), Betty A. Donoval, Joseph J. Eron(University of North Carolina at Chapel Hill), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Ronald J. Bosch(Harvard University), Mary F. Kearney, Carla Pettinelli(San Francisco General Hospital), John W. Mellors(Textron Systems (United Kingdom)), Rajesh T. Gandhi(Harvard University), Jeffrey M. Jacobson(Drexel University), John M. Coffin(Tufts University), Ellen S. Chan(Harvard University), Richard T. D’Aquila(Northwestern University), Barbara Philpotts, Sarah Read(National Institute of Allergy and Infectious Diseases), Randi Y. Leavitt(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sarah Jane Palmer(Westmead Institute), David M. Margolis(University of North Carolina at Chapel Hill)
Cited by 24
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k